Cheminformatic/bioinformatic analysis of large corporate databases: Application to drug repurposing

Drug Discovery Today: Therapeutic Strategies

Volumn 8, Issue 3-4, 2011, Pages 109-116

  Loging, William ^a   Rodriguez Esteban, Raul ^a   Hill, Jon ^a   Freeman, Tom ^a   Miglietta, John ^a  

^a BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS; CLINICAL DATA REPOSITORY; COMPUTER MODEL; DATA ANALYSIS; DATA BASE; DRUG INFORMATION; DRUG REPOSITIONING; DRUG SCREENING; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; GENETIC LINKAGE; GENETIC SCREENING; GENETIC VARIABILITY; GENOMICS; IN VITRO STUDY; IN VIVO STUDY; PHENOTYPE; REVIEW; WORKFLOW;

EID: 84861647877     PISSN: None     EISSN: 17406773     Source Type: Journal    
DOI: 10.1016/j.ddstr.2011.06.004     Document Type: Review

References (39)

1. Ashburn, T.T. and Thor, K.B. (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nat. Rev. Drug Discov. 3, 673-683 (Pubitemid 39173508)
2. Campas, C. (2009) Drug repositioning summit: finding new routes to success. Drug News Perspect. 22, 126-128
3. Tobinick, E.L. (2009) The value of drug repositioning in the current pharmaceutical market. Drug News Perspect. 22, 119-125
4. Sleigh, S.H. and Barton, C.L. (2010) Repurposing strategies for therapeutics. Pharmaceut. Med. 24, 151-159
5. Butcher, E.C. et al. (2004) Systems biology and drug discovery. Nat. Biotechnol. 22, 1253-1259
6. Pache, R. et al. (2008) Towards a molecular characterization of pathological pathways. FEBS Lett. 582, 1259-1265
7. Chatterjee, S. et al. (2009) Identification of novel genes and pathways regulating SREBP transcriptional activity. PLoS One 4, e5197
8. Oprea, T.I. et al. (2011) Associating drugs, targets and clinical outcomes into an integrated network affords a new platform for computer-aided drug repurposing. Med. Informatics 30, 100-111
9. Bascomb, N. et al. [Vicus Therapeutics] (2008) Drug combination pharmaceutical compositions and methods for their use. US20080033027 A1
10. Lipinski, C.A. et al. (1980) Bronchodilator and anti-ulcer phenoxypyrimidinones. J. Med. Chem. 23, 1026-1031
11. Reaume, A. and Saporito, M.S. [Melior Pharmaceuticals] (2007) Methods and formulations for modulating lyn kinase activity and treating related disorders. USP7, 776, 870
12. Konstantopoulis, N. et al. (2011) A gene expression signature for insulin resistance. Physiol. Genom. 43, 110-120
13. Platz, E.A. et al. (2011) A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment. Cancer Discov. 1, OF66-OF75
14. Chiang, A.P. and Butte, A.J. (2009) Systematic evaluation of drug-disease relationships to identify leads for novel drug uses. Clin. Pharmacol. Ther. 86, 507-510
15. Mas Beaventa, J.M. et al. [Anaxomics Biotech] (2011) Methods and systems for identifying molecules for processes of biological interest by using knowledge discovery in biological data. US20110098993 A1
16. Schadt, E.E. et al. (2005) Embracing complexity, inching closer to reality. Sci. STKE 295, pe40
17. Fliri, A.F. et al. (2009) Drug effects viewed from a signal transduction network perspective. J. Med. Chem. 52, 8038-8046
18. Fliri, A.J. et al. (2005) Biospectra analysis: model proteome characterizations for linking molecular structure and biological response. J. Med. Chem. 48, 6918-6925
19. Fliri, A.J. et al. (2005) Analysis of drug-induced effect patterns to link structure and side effects of medicines. Nat. Chem. Biol. 1, 389-397
20. Fliri, A.J. et al. (2007) Analysis of system structure-function relationships. Chem. Med. Chem. 2, 1774-1782
21. Russell, R.B. and Aloy, P. (2008) Targeting and tinkering with interaction networks. Nat. Chem. Biol. 4, 666-673
22. Fliri, A.J. et al. (2010) Cause-effect relationships in medicine: a protein network perspective. Trends Pharm. Sci. 31, 547-555
23. Xie, L. et al. (2011) Drug discovery using chemical systems biology: weak inhibition of multiple kinases may contribute to the anti-cancer effect of nelfinavir. PLoS Comput. Biol. 7, e1002037
24. Kinnings, S.L. et al. (2009) Drug discovery using chemical systems biology: repositioning the safe medicine comtan to treat multi-drug and extensively drug resistant tuberculosis. PLoS Comput. Biol. 5, e1000423
25. Buckley, C.E. et al. (2010) Drug reprofiling using zebrafish identifies novel compounds with potential pro-myelination effects. Neuropharmacology 59, 149-159
26. Iorio, F. et al. (2010) Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc. Natl. Acad. Sci. U.S.A. 107, 14621-14626
27. Weeber, M. (2007) Drug discovery as an example of literature-based discovery. In Computational Discovery of Scientific Knowledge (Džeroski, S. and Todorovski, L., eds), pp. 290-306, Springer
28. Agarwal, P. and Searls, D.B. (2008) Literature mining in support of drug discovery. Brief. Bioinform. 9, 479-492
29. Frijters, R. et al. (2010) Literature mining for the discovery of hidden connections between drugs, genes and diseases. PLoS Comput. Biol. 23, e1000943
30. Plake, C. and Schroeder, M. (2011) Computational polypharmacology with text mining and ontologies. Curr. Pharm. Biotechnol. 12, 449-457
31. Deftereos, S.N. et al. (2011) Drug repurposing and adverse event prediction using high-throughput literature analysis. Wiley Interdiscip. Rev. Syst. Biol. Med. 3, 323-334
32. Shaughnessy, A.F. (2011) Old drugs, new tricks. Br. Med. J. 342, d741
33. Rodriguez-Esteban, R. (2009) Biomedical text mining and its applications. PLoS Comput. Biol. 5, e1000597
34. Lu, Z. (2011) PubMed and beyond: a survey of web tools for searching biomedical literature. Database (Oxford) 2011, baq036
35. Campbell, S.J. et al. (2010) Visualizing the drug target landscape. Drug Discov. Today 15, 3-15
36. von Eichborn, J. et al. (2011) PROMISCUOUS: a database for networkbased drug-repositioning. Nucleic Acids Res. 39 (Database issue), D1060-D1066
37. Dudley, J.T. et al. (2010) Drug discovery in a multidimensional world: systems, patterns, and networks. J. Cardiovasc. Transl. Res. 3, 438-447
38. Qu, X.A. et al. (2009) Inferring novel disease indications for known drugs by semantically linking drug action and disease mechanism relationships. BMC Bioinform. 10 (Suppl. 5), S4
39. Schadt, E.E. et al. (2009) A network view of disease and compound screening. Nat. Rev. Drug Discov. 8, 286-295